DANAZOL - ENDOCRINE PHARMACOLOGY AND THERAPEUTIC APPLICATIONS

被引：201

作者：

BARBIERI, RL ^{[1
]}

RYAN, KJ ^{[1
]}

机构：

[1] BOSTON HOSP WOMEN,DEPT OBSTET & GYNECOL,BOSTON,MA 02115

来源：

关键词：

D O I：

10.1016/0002-9378(81)90611-6

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

引用

页码：453 / 463

页数：11

共 76 条

[1] ACOSTA AA, 1973, OBSTET GYNECOL, V42, P19
[2] MECHANISM OF INDUCTION OF LUTEAL PHASE DEFECTS BY DANAZOL
ASCH, RH
FERNANDEZ, EO
SILERKHODR, TM
BARTKE, A
PAUERSTEIN, CJ
[J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1980, 136 (07) : 932 - 940
[3] ASCH RH, 1979, OBSTET GYNECOL, V53, P415
[4] BARBIERI R, UNPUBLISHED
[5] DANAZOL INHIBITS HUMAN ADRENAL 21-HYDROXYLATION AND 11-BETA-HYDROXYLATION INVITRO
BARBIERI, RL
OSATHANONDH, R
CANICK, JA
STILLMAN, RJ
RYAN, KJ
[J]. STEROIDS, 1980, 35 (03) : 251 - 263
[6] DANAZOL INHIBITS STEROIDOGENESIS IN RAT TESTIS INVITRO
BARBIERI, RL
CANICK, JA
RYAN, KJ
[J]. ENDOCRINOLOGY, 1977, 101 (06) : 1676 - 1682
[7] BARBIERI RL, 1977, FERTIL STERIL, V28, P809
[8] DANAZOL AND THYROID-FUNCTION
BARBIERI, RL
[J]. ANNALS OF INTERNAL MEDICINE, 1980, 92 (01) : 133 - 133
[9] BARBIERI RL, 1979, FERTIL STERIL, V31, P185
[10] BARBIERI RL, FERTIL STERIL